The problem of prematurity: premature labour

R J Carson1

  • 1Division of Biomedical Sciences, University of Wolverhampton.

Modern Midwife
|January 10, 1998
PubMed

Insights

Predicting and preventing premature labour remains a significant challenge. Current treatments are insufficient for reducing infant mortality, highlighting the urgent need for novel therapeutic strategies.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Perinatal Research

Background:

  • Premature labour is a leading cause of neonatal morbidity and mortality.
  • Existing methods for predicting and preventing preterm birth are inadequate.
  • Current pharmacological interventions show limited efficacy in improving infant survival rates.

Purpose of the Study:

  • To review the current challenges in predicting and preventing premature labour.
  • To evaluate the effectiveness of existing treatments for preterm birth.
  • To emphasize the critical need for developing new agents to prevent premature labour.

Main Methods:

  • Literature review of current research on premature labour.
  • Analysis of the efficacy of existing drugs used in preterm birth management.
  • Identification of gaps in current knowledge and therapeutic approaches.

Main Results:

  • Premature labour cannot be reliably predicted with current methods.
  • Effective prevention strategies for premature labour are lacking.
  • Current drugs do not significantly reduce infant mortality associated with preterm birth.

Conclusions:

  • There is a significant unmet need for improved prediction and prevention of premature labour.
  • Further research and development of novel therapeutic agents are essential.
  • Effective interventions are crucial to reduce infant mortality and improve outcomes for premature infants.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...